PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS)

0.193
Delayed Data
As of 4:00pm ET
 -0.064 / -24.90%
Today’s Change
0.18
Today|||52-Week Range
4.10
-92.61%
Year-to-Date
No recent news for PhaseBio Pharmaceuticals Inc.

Today’s Trading

Previous close0.26
Today’s open0.25
Day’s range0.18 - 0.25
Volume87,281
Average volume (3 months)383,093
Market cap$40.3M
Data as of 4:00pm ET, 09/29/2022

Growth & Valuation

Earnings growth (last year)+12.02%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.58
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd0.000.00%
----
OBSVObseva SA-0.01-3.61%
--Kyto Technology and ...0.000.00%
Data as of 3:45pm ET, 09/29/2022

Financials

Next reporting dateNovember 17, 2022
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$10.8M
Annual profit (last year)-$131.1M
Net profit margin-1,210.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Malvern, Pennsylvania

Forecasts